ACT Capital Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,250	Closed	-$418K	–	85
2022 Q1	$418K	Hold	1,250	–	–	0.44%	37
2021 Q4	$407K	Sell	1,250 -1,875	-60%	-$611K	0.29%	49
2021 Q3	$1.52M	Buy	3,125 +500	+19%	+$243K	0.79%	30
2021 Q2	$1.22M	Buy	+2,625	New	+$1.22M	0.63%	35